• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -NasdaqCM
    12.84 Down 0.09(0.70%) May 22, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development10,273  10,533  6,376  
    Selling General and Administrative7,566  8,472  6,403  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (17,839) (19,005) (12,779)
    Income from Continuing Operations
    Total Other Income/Expenses Net(371)(19,621)17,515  
    Earnings Before Interest And Taxes(18,210)(38,626)4,736  
    Interest Expense136  130  72  
    Income Before Tax(18,346)(38,756)4,664  
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(18,346)(38,756)4,664  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (18,346) (38,756) 4,664  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (18,346) (38,756) 4,664  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.